Spectrum Pharmaceuticals Inc (NASDAQ:SPPI)
| 1.38 Delayed Data As of 3:59pm ET |  +0.165 / +13.64%Today’s Change | 0.60 Today|||52-Week Range 2.53 | +8.27% Year-to-Date |
Latest SPPI News | Press Releases
| Spectrum Pharmaceuticals (SPPI) Q2 2022 Earnings Call Transcript 3:30am / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.21 |
| Today’s open | 1.23 |
| Day’s range | 1.23 - 1.38 |
| Volume | 85,224 |
| Average volume (3 months) | 2,114,025 |
| Market cap | $189.1M |
Data as of 3:59pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | +20.80% |
| Earnings growth (this year) | +50.25% |
| Earnings growth (next 5 years) | +22.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SMMTSummit Therapeutics ... | -0.02 | -1.83% |
| GSGTFGensight Biologics S... | 0.00 | 0.00% |
| MRNSMarinus Pharmaceutic... | +0.04 | +0.69% |
| CMRXChimerix Inc | +0.31 | +12.97% |
Data as of 4:00pm ET, 08/12/2022
Financials
| Next reporting date | November 10, 2022 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$158.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Henderson, Nevada |
Forecasts
